Holen Sie sich die Stockscreener-App
11.33
0.53%
0.06
Handel nachbörslich:
11.33
Keen Vision Acquisition Corp Aktie (KVAC) Neueste Nachrichten
Short Interest in Keen Vision Acquisition Co. (NASDAQ:KVAC) Rises By 33.3% - MarketBeat
Boothbay Fund Management LLC Has $278,000 Stock Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Berkley W R Corp Trims Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
AQR Arbitrage LLC Has $4.88 Million Stock Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Quarry LP Lowers Stake in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition extends merger deadline By Investing.com - Investing.com Canada
KVAC stock soars to all-time high, reaching $11.28 By Investing.com - Investing.com South Africa
Spartan Fund Management Inc. Makes New Investment in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high, reaching $11.28 - Investing.com
Keen Vision Acquisition extends merger deadline - Investing.com Australia
Medera to Go Public through Merger with KVAC - CHEManager
KVACWKeen Vision Acquisition Corp Latest Stock News & Market Updates - Stock Titan
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Down 62.5% in March - MarketBeat
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of PLYA, LTRPA, MHLD, KVAC to Act Now - Morningstar
Yakira Capital Management Inc. Buys New Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high of $11.26 amid market optimism - Investing.com Canada
KVAC stock soars to all-time high of $11.26 amid market optimism By Investing.com - Investing.com South Africa
Press Release Distribution & PR Platform - ACCESS Newswire
Medera Presented Updated Results from First-In-Human Gene - GlobeNewswire
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit - Yahoo Finance
Keen Vision Acquisition Co. (NASDAQ:KVAC) Sees Significant Growth in Short Interest - MarketBeat
KVAC stock soars to all-time high, touches $11.25 By Investing.com - Investing.com Canada
Keen Vision Acquisition Corp. Secures Funding to Extend Merger Deadline By Investing.com - Investing.com Australia
KVAC stock soars to all-time high, touches $11.25 - Investing.com
Keen Vision Acquisition Corp. Secures Funding to Extend Merger Deadline - Investing.com India
Mizuho Securities USA LLC Has $11.10 Million Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition (NASDAQ:KVAC) Trading 0.2% HigherStill a Buy? - MarketBeat
Keen Vision Acquisition (NASDAQ:KVAC) Shares Up 0.2% – What’s Next? - Defense World
KVAC stock soars to all-time high of $11.19 amid market optimism - Investing.com Australia
KVAC stock soars to all-time high of $11.19 amid market optimism By Investing.com - Investing.com South Africa
Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction - GlobeNewswire
STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerNHHS, KVAC, AMPS, AVTE - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – NHHS, KVAC, AMPS, AVTE - GlobeNewswire Inc.
Medera Completes Patient Dosing for Heart Failure Treatment - Yahoo Finance
Medera completes patient dosing in Phase 1/2a MUSIC-HFrEF - TipRanks
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF - GlobeNewswire
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction - Yahoo Finance
0.41%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):